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Abstract
The objective of our study was to estimate direct healthcare costs incurred by a population-
based sample of people with psychological distress or depression. We used the 2002 Cana-
dian Community Health Survey on Mental Health and Well Being and categorized individu-
als as having psychological distress using the Kessler-6, major depressive disorder (MDD)
using DSM-IV criteria and a comparison group of participants without MDD or psychological
distress. Costs in 2013 USD were estimated by linking individuals to health administrative
databases and following them until March 31, 2013. Our sample consisted of 9,965 individu-
als, of whom 651 and 409 had psychological distress and MDD, respectively. Although the
age-and-sex adjusted per-capita costs were similarly high among the psychologically dis-
tressed ($3,364, 95% CI: $2,791, $3,937) and those with MDD ($3,210, 95% CI: $2,413,
$4,008) compared to the comparison group ($2,629, 95% CI: $2,312, $2,945), the popula-
tion-wide excess costs for psychological distress ($441 million) were more than twice that
for MDD ($210 million) as there was a greater number of people with psychological distress
than depression. We found substantial healthcare costs associated with psychological dis-
tress and depression, suggesting that psychological distress and MDD have a high cost bur-
den and there may be public health intervention opportunities to relieve distress. Further
research examining how individuals with these conditions use the healthcare system may
provide insight into the allocation of limited healthcare resources while maintaining high
quality care.
Introduction
Depression is an important public health concern that impacts approximately 350 million peo-
ple worldwide [1] and is the third leading cause of disability globally [2]. In the United States,
approximately 19.2% of adults experienced a major depressive episode at some point in their
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lives, while in Canada, the prevalence was 11.3% [3,4]. In addition to people with major
depressive disorder (MDD), there are individuals who exhibit psychological distress, a more
prevalent nonspecific condition characterized by symptoms of depression, anxiety and related
somatic symptoms [5]. Psychological distress is associated with low socioeconomic status,
unemployment, poor health and increased risk of mortality [6,7]. Despite the increased health
burden of depression, few population-based cohort studies have examined the costs associated
with major depression and far fewer studies have examined costs related to psychological dis-
tress [8].
Previous costing studies for depression have focused on patients in primary care or psychi-
atric care settings rather than population-based samples, which may be more representative of
all people with depression, particularly those who do not seek health services [9–11]. Many
studies have also estimated costs with limited adjustment for confounding factors, such as age,
sex, income, lifestyle risk factors, and somatic illnesses [10,12,13]. Moreover, previous studies
examining the cost of psychological distress did not have an MDD group for cost comparison
and often relied on self-reported healthcare utilization [14,15]. Finally, there is insufficient
evidence on which healthcare sectors are most associated with depression and psychological
distress.
The primary objective of this study was therefore to determine the direct healthcare costs
associated with psychological distress and major depression in Ontario. The secondary objec-
tives were to understand how these costs vary by healthcare sector and what proportion of
total costs were for mental health and addictions (MHA) versus non-MHA related healthcare
services.
Methods
Study population
We used the Ontario sample of the Canadian Community Health Survey on Mental Health
andWell Being, cycle 1.2 (CCHS 1.2) conducted by Statistics Canada in 2002 to select our
study cohort. The CCHS 1.2 is a nationally representative community mental health survey of
individuals aged 15 years or older living in private dwellings. The survey excluded individuals
living on Indian Reserves and on Crown Lands, institutional residents, full-time members of
the Canadian Forces, and residents of certain remote regions (98% coverage; 77% response
rate) [16].
Using individual encrypted health card numbers, we anonymously linked survey respon-
dents to multiple health administrative databases housed at the Institute for Clinical Evaluative
Sciences (ICES) (S1 Table). We excluded respondents with invalid health card numbers or
those without eligibility at baseline or a year prior which were required for data linkage and
ascertaining covariates. Given our focus on psychological distress and depression, we excluded
respondents with a hospitalization for bipolar disorder or schizophrenia/schizoaffective disor-
der in the past 5 years, as well as those who self-reported schizophrenia, any other psychoses,
past year mania, dysthymia, or eating disorders (see S1 Table for codes). Given the cohort was
recruited in 2002, the year ICD10 was implemented in Ontario Canada, parts of the 5-year
lookback period used both ICD10 and ICD9 codes.
Definitions of major depression, psychological distress and comparison
groups
The CCHS 1.2 used the version of the World Health Organization (WHO)World Mental
Health Composite International Diagnostic Interview (WMH-CIDI) [16] designed to assess
Healthcare costs of psychological distress and depression
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the prevalence and burden of mental illness based on the definitions and criteria of the Diag-
nostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) systems [16].
In our study, the major depressive disorder (MDD) group included respondents who met
the criteria for past 12-month MDD [16]. Among those who did not meet the criteria for
MDD, those who scored 8 or more out of 24 on the Kessler 6 (K6) scale [17] were included in
the psychological distress group. The K6 has been shown to be an effective screening instru-
ment for psychological distress in the general population [7,18]. The remaining individuals
comprised the comparison group.
Cost estimations
Cost methodology. Costs for hospitalizations, ED visits, and outpatient visits were cap-
tured within health administrative databases (S1 Table). All billings by psychiatrists and MHA
visits billed by primary care physicians were considered MHA costs. We used a validated algo-
rithm by Steele et al. [19] to identify MHA visits billed by primary care physicians (i.e. family
physicians and general practitioners). All other outpatient physician billings were considered
non-MHA costs. Costs for hospitalizations or ED visits that were coded with a primary diagno-
sis of ICD-10 F00-F99 were considered MHA, while all other codes were considered non-
MHA. All costs accrued in the Ontario Mental Health Reporting System were considered
MHA costs. Other healthcare costs included: drug costs for those aged 65 years or over, other
hospital, ambulatory care, long-term care, home care and devices (S2 Table). All costs were esti-
mated using costing methods previously described in guidelines for person level costing [20].
Per-capita costs. For each individual, we estimated costs incurred from the survey inter-
view date (2002) to the earliest of death, loss of healthcare eligibility or March 31, 2013 (end
of study period), such that maximum follow-up was approximately 11 years. All costs were
divided by the total length of follow-up to estimate annualized costs and inflated to 2013 val-
ues. These were then presented in United States Dollars (USD) using the OECD defined Cana-
dian Dollar (CAD)-USD Purchasing Power Parities averaged over the study time period (1
CAD = 0.82 USD) [21]. We estimated the mean overall costs for each study group by both
healthcare sector (i.e. physician, ED, hospital, and other) and MHA status (MHA spending,
non-MHA spending).
Statistical analysis
For outcomes with non-zero costs (i.e. Total Outpatient, All Costs, All Non-MHA Costs), we
used a generalized linear model with a gamma distribution and a log link. For outcomes that
included both zero and non-zero outcomes (i.e. all other cost categories), we used a two-part
model, where the first part models whether costs occurred using a probit model and the sec-
ond part models the level of costs among those with non-zero costs, conditional on incurring
costs using a generalized linear model with a gamma distribution and a log link [22]. The
choice of the distribution for the second part was based on the results of the modified Park
test [22,23]. We modelled each sector of costs (i.e. Outpatient, ED, hospital, drug, ambulatory,
and each type of other costs) and total costs by MHA status (MHA costs, non-MHA costs)
separately.
Results from the two-part models are shown as predicted per-capita costs and per-capita
cost differences using marginal standardization to estimate the predicted costs [24]. Per-capita
excess costs were calculated by comparing costs in each exposure group to the comparison
group. Excess cost was defined as the difference between the cost in each exposure group and
the cost in the comparison group, to reflect the cost above and beyond those expected in the
comparison group. Statistical tests compared the costs in each exposure group relative to the
Healthcare costs of psychological distress and depression
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comparison group and compared the two exposure groups. All results were weighted by the
survey weights to allow generalizability to the overall Ontario population and bootstrap meth-
ods were used to calculate confidence intervals. Analyses were conducted using STATA v13.1.
We estimated unadjusted, age- and sex-adjusted, and multivariable-adjusted costs. Multi-
variable-adjusted models included covariates measured at baseline that are thought to be asso-
ciated with costs and mental health. Most covariates were derived from the survey responses
including: age, sex, marital status (married/common law vs other), residence (urban vs rural),
ethnicity (white vs non-white), immigrant status (immigrant vs non-immigrant) [25], current
smoking (yes/no) [26], physical inactivity (i.e., energy expenditure<1.5 kcal/kg/day) [27],
body-mass index [27]. The remaining covariates were derived from administrative databases
including area-level low income status (quintiles 1–2 vs 3–5) [28] measured at the level of the
dissemination area and five measures of baseline medical comorbidities ascertained using vali-
dated algorithms [29–34]; i.e. cardiovascular diseases, cancer, respiratory conditions, hyper-
tension and diabetes.
To estimate the weighted number of individuals within each group we summed up the sam-
ple weights of all respondents within each group. To calculate the age- and sex-adjusted popu-
lation-wide costs or population-wide excess costs, we multiplied the weighted sample size
within each group by the age- and sex-adjusted per-capita cost or per-capita excess costs
within each study group.
Results
From a total of 10,662 initial survey respondents, we excluded 356 respondents with other seri-
ous mental illnesses and 145 individuals without healthcare eligibility at baseline and a year
prior to baseline, and 6 individuals withdata errors (i.e. 4 with a survey date outside recruit-
ment window, 2 with a death data prior to the survey date suggesting a possible data linkage
error). There was a total of 190 (1.7%) missing observations which were excluded from the
analysis. Our final sample consisted of 9,965 individuals: 651 with psychological distress, 409
with MDD and 8,905 comparison group individuals (Table 1). The weighted prevalence of
psychological distress and MDD was 6.6% and 3.9%, respectively. Median follow-up time was
10.6 years in all exposure groups. Individuals with psychological distress and MDD were sig-
nificantly younger than the comparison group (40.8 and 39.3 vs. 44.3 years, respectively) and
were less likely to be married or in common-law relationships (p<0.001) (Table 1).
Average annual per-capita direct healthcare costs
Our findings were consistent across unadjusted, age- and sex-adjusted, and multivariate
adjusted models; below, we focus on age- and sex-adjusted results.
The annual per-capita total costs were similar between the psychological distress ($3,364,
95% CI: $2,791, $3,937) and MDD ($3,210, 95% CI: $2,413, $4,008) groups and both had
higher costs than the comparison group ($2,629, 95% CI: $2,312, $2,945) (Table 2). The psy-
chological distress and MDD groups incurred higher healthcare costs in all sectors examined
(i.e. outpatient, ED, hospital and other healthcare sectors) (Table 3). The MDD group had sig-
nificant excess ED costs ($41, 95% CI: $7, $74) and larger but non-significant excess total costs
($582, 95% CI: -$360, $1,524) compared to the comparison group. When psychological distress
and MDD groups were compared, outpatient and ED excess costs were similar (excess per-
capita cost< $35 and p> 0.60 in both cases). Cost-differences for hospital, other non MHA,
total, and total non-MHA were also not significantly different between depressed and psycho-
logical distressed individuals (p> 0.19 in all cases). We observed a dose-response relationship
across psychological distress, MDD, and increased MHA costs; both were significantly greater
Healthcare costs of psychological distress and depression
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than the comparison group (excess per-capita cost: $68, p = 0.04 and $364, p = 0.003, respec-
tively) and MHA costs were significantly greater among depressed individuals compared to
those with psychological distress ($296, p = 0.02)(Table 3). As a percentage of total costs,
MHA-related costs were greater among the MDD group (13.5%) relative to the psychological
distress group (4.1%), which interestingly was similar to thecomparison group (2.7%)
(Table 2). Although MHA costs were lower in the psychological distress group relative to the
MDD group, they incurred greater non-MHA costs than the MDD group (Table 3).
Population-wide costs
At the population level, 599,047 were psychologically distressed, 361,389 had MDD, and
8,260,184 individuals had neither condition. The age-and-sex adjusted annual absolute health-
care costs were $2.0 billion for the psychologically distressed population and $1.2 billion for
the MDD population (Fig 1 and S3 Table). This represented an excess of $441 (95% CI: $16,
$865) million for the psychologically distressed population and $210 (95% CI: -$130, $551)
million for the MDD population compared to the comparison group (Fig 1 and S3 Table) as
there was a greater number of people with psychological distress than depression.
Discussion
To our knowledge, this study is the first population-based cohort study to estimate the direct
healthcare costs associated with individuals with psychological distress who do not meet the
Table 1. Sociodemographic and risk factor profile of those with psychological distress, major depressive disorder (MDD) and the comparison
group at baseline (n = 9,965)a.
Comparison Group
(CG)
Psychological distress
(PD)
P-valuesf (PD vs.
CG)
MDD P-valuesf (MDD
vs. CG)
P-values (MDD
vs. PD)
Unweighted N 8905 651 409
Mean age (years) 44.3 40.8 0.001 39.3 0.001 0.24
Male sex 50.6 46.4 0.12 36.9 0.001 0.053
Married/Common Law 65.0 55.6 0.001 48.5 0.001 0.11
Urban residence 82.8 86.9 0.09 80.7 0.57 0.15
Income quintile 1–2 40.3 47.1 0.018 42.0 0.63 0.30
Non-white ethnicity 21.5 25.9 0.10 16.2 0.21 0.055
Non-immigrant 68.0 64.2 0.20 71.9 0.36 0.13
Body-mass index (BMI), mean
(median)b
25.5 (24.9) 25.4 (24.8) 0.59 25.1
(23.8)
0.31 0.62
Cigarette smoker 26.1 31.6 0.01 46.6 0.001 0.001
Physical inactivityc 45.4 57.5 0.001 56.9 0.003 0.89
Cardiovascular diseasesd 2.4 3.7 0.12 1.4 0.31 0.09
Cancer 3.9 2.6 0.24 1.7 0.11 0.50
Respiratory conditionse 13.2 15.0 0.32 18.2 0.02 0.30
Hypertension 20.7 18.5 0.26 14.4 0.01 0.17
Diabetes 6.0 8.1 0.10 5.2 0.59 0.16
a % unless otherwise specified; all values weighted by sample weights, bootstrap methods used to determine P-values
b BMI was based on self-reported height and weight in kg/m2
c Physical inactivity includes energy expenditure of 1.5 kcal/kg/day
d Cardiovascular diseases include acute myocardial infarction and congestive heart failure
e Respiratory conditions include chronic obstructive pulmonary disease and asthma
f P-values generated based on comparisons to the comparison group; t-tests for continuous variables and chi-square test for binary variables
https://doi.org/10.1371/journal.pone.0184268.t001
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criteria for depression, compared to those with MDD and the comparison group with neither
condition. Our study found that individuals with psychological distress and MDD incurred
greater direct healthcare costs per capita than the comparison group, with significantly large
excess outpatient and ED costs. Although on a per-capita basis, individuals with elevated dis-
tress have similar costs to those with depression, their annual population-wide costs were
almost twice the cost burden associated with depression. Despite similar costs, only 4% of the
Table 2. Per-capita absolute costs incurred by those with psychologically distressed, major depressive disorder (MDD) and comparison group
per person year (prices in 2013 USD)a.
Comparison Group Psychological distress MDD
Outpatient
Unadjustedd 790 (721–858) 894 (798–989) 850 (731–969)
Age-sex adjustedd 809 (725–893) 979 (869–1,088) 944 (802–1,085)
Multivariable adjustedd 817 (743–891) 979 (877–1,081) 956 (831–1,082)
Emergency Department
Unadjusted 99 (89–110) 135 (113–156) 118 (96–139)
Age-sex adjusted 97 (85–108) 139 (118–160) 137 (109–165)
Multivariable adjusted 100 (88–111) 130 (113–148) 129 (103–154)
Hospital
Unadjusted 942 (831–1,052) 975 (740–1,210) 1,014 (586–1,441)
Age-sex adjusted 880 (756–1,004) 1,011 (770–1,253) 1,139 (661–1,616)
Multivariable adjusted 928 (785–1,072) 988 (778–1,197) 1,122 (712–1,532)
Other healthcareb
Unadjusted 874 (795–953) 1,337 (973–1,700) 840 (502–1,179)
Age-sex adjusted 786 (671–901) 1,199 (699–1,699) 819 (516–1,122)
Multivariable adjusted 902 (772–1,032) 1,388 (769–2,007) 839 (567–1,111)
All costs
Total
Unadjustedd 2,704 (2,493–2,916) 3,340 (2,770–3,910) 2,822 (2,086–3,557)
Age-sex adjustedd 2,629 (2,312–2,945) 3,364 (2,791–3,937) 3,210 (2,413–4,008)
Multivariable adjustedcd 2,831 (2,529–3,133) 3,411 (2,856–3,965) 3,223 (2,502–3,944)
Mental Health or Addictions (MHA)
Unadjusted 73 (53–93) 114 (65–163) 359 (171–548)
Age-sex adjusted 70 (52–88) 138 (74–203) 434 (192–677)
Multivariable adjustedc 72 (54–91) 132 (75–189) 487 (184–789)
Non-MHA
Unadjustedd 2,631 (2,421–2,842) 3,226 (2,657–3,796) 2,462 (1,774–3,150)
Age-sex adjustedd 2,567 (2,248–2,886) 3,214 (2,646–3,782) 2,667 (1,996–3,338)
Multivariable adjustedcd 2,770 (2,464–3,077) 3,269 (2,716–3,822) 2,628 (2,056–3,201)
% of total costs that are for MHA-related health services
Unadjusted 2.7 3.4 12.7
Age-sex adjusted 2.7 4.1 13.5
Multivariable adjustedc 2.5 3.9 15.1
a All values weighted by sample weights, bootstrap methods used to determine 95% confidence intervals
b Outpatient prescriptions for adults age 65 and older, non-hospital based residential care, ambulatory care, home care, medical devices
c Adjusted for age, sex, marital status, urban vs rural residence, area-level low income status (quintiles 1–2 vs 3–5), white vs non-white ethnicity, immigrant
status, smoking, physical inactivity (energy expenditure 1.5 kcal/kg/day) body-mass index, cardiovascular diseases, cancer, respiratory conditions,
hypertension and diabetes.
d One part models were used, all other models were two-part models
https://doi.org/10.1371/journal.pone.0184268.t002
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costs incurred by those with psychological distress are associated with MHA-related health ser-
vices compared to 14% among individuals with depression, suggesting that individuals with
psychological distress may not be identified or treated for their mental health condition. We
acknowledge that some of the non-MHA costs are due to higher chronic conditions, although
at baseline none of the major chronic diseases were significantly more prevalent among indi-
viduals with psychological distress than in the comparison group and adjustment for chronic
conditions resulted in minimal changes to the results. Our findings emphasize the need to bet-
ter understand psychological distress and reasons for these elevated healthcare costs.
Table 3. Age- and sex-adjusted per-capita excess costs incurred by those with psychological distress and major depressive disorder (MDD) com-
pared to the comparison group per person year (prices in 2013 USD)a.
Psychological distress MDD
Difference (95% CI) p-value Difference (95% CI) p-value
Outpatient
Unadjustede 104 (-17–226) 0.093 61 (-77–198) 0.389
Age-sex adjustede 170 (16–324)b 0.031 135 (-56–326) 0.165
Multivariable adjustede 162 (43–281)b 0.008 139 (4–275)b 0.044
Emergency Department
Unadjusted 36 (12–60)b 0.004 19 (-6–43) 0.132
Age-sex adjusted 43 (17–68)b 0.001 41 (7–74)b 0.018
Multivariable adjusted 31 (12–50)b 0.001 29 (4–55)b 0.024
Hospital
Unadjusted 34 (-228–295) 0.801 72 (-379–523) 0.754
Age-sex adjusted 131 (-176–439) 0.403 259 (-272–789) 0.34
Multivariable adjusted 59 (-188–306) 0.638 194 (-226–614) 0.365
Other healthcarec
Unadjusted 463 (91–834)b 0.015 -34 (-382–315) 0.849
Age-sex adjusted 413 (-129–954) 0.135 33 (-316–381) 0.855
Multivariable adjusted 486 (-162–1,134) 0.142 -62 (-364–239) 0.684
All costs
Total
Unadjustede 636 (20–1,252)b 0.043 117 (-663–897) 0.768
Age-sex adjustede 735 (27–1,444)b 0.042 582 (-360–1,524) 0.226
Multivariable adjustedde 580 (-71–1,230) 0.081 392 (-362–1,147) 0.308
Mental Health or Addictions (MHA)
Unadjusted 41 (-13–94) 0.136 287 (98–475)b 0.003
Age-sex adjusted 68 (4–133)b 0.038 364 (125–604)b 0.003
Multivariable adjustedd 60 (7–113)b 0.027 414 (118–711)b 0.006
Non-MHA
Unadjustede 595 (-20–1,210) 0.058 -169 (-901–563) 0.65
Age-sex adjustede 647 (-54–1,348) 0.071 100 (-718–918) 0.81
Multivariable adjustedde 499 (-150–1,148) 0.132 -142 (-748–464) 0.646
a All values weighted by sample weights, bootstrap methods used to determine 95% confidence intervals
b Significant results (i.e. 95% confidence interval for the difference does not cross $0)
c Outpatient prescriptions for adults age 65 and older, non-hospital based residential care, ambulatory care, home care, medical devices
d Adjusted for age, sex, marital status, urban vs rural residence, area-level low income status (quintiles 1–2 vs 3–5), white vs non-white ethnicity, immigrant
status, smoking, physical inactivity (energy expenditure 1.5 kcal/kg/day) body-mass index, cardiovascular diseases, cancer, respiratory conditions,
hypertension and diabetes.
e One part models were used, all other models were two-part models
https://doi.org/10.1371/journal.pone.0184268.t003
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Very few previous studies have investigated the association between psychological distress
and healthcare costs [8,14,15,35,36]; most have been based on the US Medical Expenditure
Panel Survey and none included a validated depressed group for comparison [8,14,15]. These
studies have consistently shown that psychological distress is associated with significant
healthcare expenditures compared to those without psychological distress [8,14,15,35,36].
Results from a contemporaneous survey in the U.S. showed psychological distress was signifi-
cantly associated with $1,735 higher total per capita excess expenditures, $1,000 higher than
Fig 1. Population-wide annual absolute (Panel A) and excess (Panel B) direct health care costs (2013
USD) incurred by people with psychological distress and depression in Ontario, Canadaa. a All values
weighted by sample weights. Analyses were adjusted for age and sex. Bootstrap methods were used to
determine the 95% confidence intervals (i.e. the 2.5th and 97.5th percentiles of 500 bootstrap estimates).
https://doi.org/10.1371/journal.pone.0184268.g001
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our estimate. This may be driven by differences in methodology (e.g. use of self-reported utili-
zation to derive costs, different cut-off value on the K6 scale) and differences in health systems
[14].
A primary finding of our study was that individuals with psychological distress cost the
healthcare system a similar amount on a per-capita basis as those with MDD. Our findings are
similar to results from a US study, which showed no statistically significant differences in costs
between elderly patients with subthreshold depressive symptoms, a similar condition to psy-
chological distress, and those with DSM-IV depressive disorders [9]. However, a Dutch study
found the medical cost of minor depression to be considerably lower than the medical cost of
major depression [37]. The Dutch study derived costs from self-reported medical consump-
tion and may be subject to respondent bias, while our estimates were derived from a large pop-
ulation-based cohort using objective healthcare cost data from administrative databases.
Another key finding is the dose-response gradient in mental health costs across the study
groups. In a study by Kleine-Budde et al. [38], mean annual depression-specific healthcare
costs for persons with severe depression were twice as high as those for individuals with mod-
erate depression and five times higher than those with mild depression. This dose-response
relationship was also observed for total costs among those with increasing levels of psychologi-
cal distress [15]. Moreover, our findings on sector-specific costs were comparable to results
found in a study by Katon et al. [9], such that outpatient costs were significantly higher in both
the minor and major depression groups compared to the comparison group. ED visit costs
were significantly higher in both groups in our study and although elevated in both groups in
the Katon et al. [9] study, it was only significant among those with minor depression. In our
study, we also observed that non-MHA costs were higher for those with psychological distress
than MDD. This can be attributed to the fact that individuals suffering from psychological dis-
tress often seek help for their unexplained physical symptoms, but may not be diagnosed or
treated as mental health conditions [39].
Our study showed that the per-capita excess costs of psychological distress and MDD were
$897 and $709 respectively. A systematic review by Luppa et al. [40] demonstrated that excess
direct costs among the subclinically depressed compared to the comparison group ranged
from $789 to $2,263, whereas excess costs for depressed ranged from $324 to $5,871 per person
per year. Our estimates of costs lie on the lower end of this range perhaps because we could
not include the cost of drugs, laboratory tests or non-physician, ED and hospital-based ser-
vices. In general, it is difficult to compare costs across jurisdictions as there is often variability
in health systems, available services, populations and patterns of health service utilization [40];
this underscores the value of Canadian-specific cost estimates for these important psychologi-
cal conditions.
This study has several strengths. First, unlike previous studies [14,36], the linkage of our
study cohort to several health administrative databases allowed us to directly measure prospec-
tive longitudinal costs for the full follow-up period for almost all individuals without relying
on personal retrospective recall of healthcare utilization. Second, MDD was determined
through a validated structured diagnostic interview (CIDI DSM-IV) [41–43] and our measure
of psychological distress was determined using the K6 scale which has been shown to be useful
for screening purposes [18,44]. Third, unlike previous studies that often estimated costs for
MDD from clinical samples, our study used a population-based sample and survey weights
were applied in all models allowing generalizable cost estimates enabling the calculation of
per-capita and population-wide costs. Fourth, the universal healthcare system in Ontario
reduces the issue of access to physician and hospital care for patients with limited financial
means for paying for care. Finally, this study was able to control for important covariates at
baseline, including chronic medical conditions. Nevertheless, we acknowledge that there may
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be additional factors that jointly influence depression or psychological distress and healthcare
costs that we are unable to control for.
This study also has some limitations that need to be considered. First, the CCHS excluded
certain vulnerable populations [16], some of whommay have elevated burden of psychiatric
disorders, therefore our cost estimates are likely conservative. Second, given that MDD or
distress status and covariates were only assessed at baseline and costs were assessed over an
11-year follow-up period, we were unable to appropriately account for time. It is conceivable
that individuals may have moved between exposure groups during the 11-year follow-up
period or major (ecological) events have occurred during the 11-year follow-up period that
may have affected costs. Third, we were not able to capture drug costs for adults under age 65
years or community mental health and addictions services. Moreover, costs for outpatient psy-
chological counselling were not captured as they are largely covered through employer-based
insurance or paid out-of-pocket. All of these cost categories (i.e. drug, community mental
health and addiction services, counselling) are likely to be greater among individuals with psy-
chological problems and therefore resulting in an underestimate of the total healthcare costs
among those with psychological distress and depression. This might suggest that our estimates
of healthcare costs are likely conservative. However, a prior review suggested that only a small
proportion of the excess healthcare costs among depressed patients are accounted for by
depression treatment costs suggesting the underestimate is not substantial [45]. Nevertheless,
the universal healthcare system in Ontario and the availability of data from most major health-
care sectors at the patient-level allowed us to capture the majority of direct healthcare costs.
We were also limited in determining whether the care received was for disease management or
preventive care. Given higher ED and primary care costs, this may signal that despite elevated
primary care use, these individuals are not receiving adequate mental health care in the pri-
mary care setting to fully address their needs and prevent ED visits. Future work is necessary
to examine the quality of primary mental health care received and whether unmet needs for
care are driving higher emergency department visits.
Conclusions
In this population-based study, we found that people with psychological distress and major
depression incurred similar per-capita direct healthcare costs and these costs were greater than
those without either condition. These two groups differed in the way the totals were reached,
with depressed individuals incurring higher mental health and addiction-related costs and psy-
chologically distressed individuals incurring higher non-mental health and addiction costs.
Given the high prevalence of psychological distress, at the population level, this group incurred
almost twice the healthcare costs compared to individuals with major depression, despite not
meeting the clinical cut-off for MDD. The elevated rate of contact with the healthcare system
among patients with psychological distress provides an opportunity for them to be identified
and receive mental healthcare. Further research is needed to examine whether identifying and
treating psychological distress will result in short- or long-term cost savings.
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